InMed Pharmaceuticals
INM----
InMed Pharmaceuticals (INM)
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States. The company operat...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
InMed Pharmaceuticals Analyst Rating
View MoreForecast & Rating
Feb 29, 2024Price forecast
$409.5323849.39%
Forecast & Rating-
0analysts
News
- Global Report · 43 minutes ago
The 2026 Earnings Paradox: Record Revenues Meet Hidden Credit Cracks
- Global Report · 47 minutes ago
The Biotech Survival Charade: Stop Buying the "AI Pivot" Hype
- Global Report · 1 day ago, 04:14 AM
The Great Unbundling of 2026: From AI Platforms to Physical Constraints
- Global Report · 2 days ago, 04:13 AM
The 2026 Biotech Divide: When Generative Biology Meets the FDA Wall
- Price Alert · 2 days ago, 04:12 AM
Pre-market hot trades in US stocks: AsiaStrategy pre-market down 9.91%; InMed Pharmaceuticals pre-market down 9.04%
- US Stock Market Update · Jul 22 at 04:21 PM
InMed Pharmaceuticals rises 8% in after-hours trading
